Stryker SYK

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. Stryker Delivers Solid First-Quarter Performance; No Change to our Fair Value Estimate

      Commentary

      Tue, 21 Apr 2015

      Stryker reported solid first-quarter performance ..... Despite heavy foreign exchange headwinds, Stryker 's underlying top-line growth remains ..... revenue growth coming from all three of Stryker 's segments, the firm remains in a good

    2. Global Joint Reconstruction Market Analysis, Size, Share, Growth, Trends and Forecast 2015-2019

      Commentary

      Thu, 2 Apr 2015

      in this market. Key Regions Americas APAC EMEA Key Vendors DePuy Synthes (a Johnson & Johnson Company) Smith & Nephew Stryker Zimmer Holdings Other Prominent Vendors Aesculap Implant Systems (a B. Braun company) Arthrex ConforMIS Corenetec Corin

    3. Global Patient Temperature Management Market 2015-2019

      Commentary

      Fri, 20 Feb 2015

      vendors operating in this market. Key Regions Americas APAC EMEA Key Vendors 3M Healthcare C. R. Bard Smiths Medical Stryker ZOLL Medical Other Prominent Vendors Augustine Temperature Management Belmont Instrument Charter Kontron Cincinnati Sub

    4. Zimmer on Cusp of Closing Biomet Deal; Our Fair Value Estimate Remains Unchanged

      Commentary

      Thu, 29 Jan 2015

      markets. Nonetheless, we think how the regulators handle the Zimmer-Biomet situation may be instructive for any peer that might be taking a close look at Smith & Nephew as a target (we still think Stryker is the most likely taker).

    5. Stryker Sets Sights on Stronger European Growth in 2015; Fair Value Estimate Increase Likely

      Commentary

      Tue, 27 Jan 2015

      Stryker reported fourth-quarter results that were ..... stronger growth from the European region as Stryker reorganizes its structure there, and peripherally ..... realized since our last update. We still think Stryker enjoys a wide economic moat, bolstered

    6. Zimmer Delivers Solid 3Q, but Still Awaits Antitrust Clearance for Biomet Acquisition

      Commentary

      Thu, 23 Oct 2014

      fell 250 basis points, which stands in contrast with the 500 basis points J&J saw and the 300-500 basis point erosion Stryker experienced. Management comments indicated hospital contracts have eased up on price, and pointed to extensive registry

    7. Stryker Delivers Strong 3Q With More to Come as Acquisitions Are Integrated

      Commentary

      Fri, 17 Oct 2014

      Stryker reported strong third-quarter results ..... before deductibles are reset in January. Stryker 's ability to gain volume more than offsets ..... marketing expense. We were impressed by Stryker 's reconstruction business, which posted

    8. Top 10 Buys and Sells by the Ultimate Stock-Pickers

      Headlines

      Wed, 3 Sep 2014

      Wide 78.56 1.08 67,980 2 Stryker SYK 3 Medium Wide 83.31 1.05 31,784 2 Data ..... about his sale of wide-moat rated Stryker SYK , which was completely out of the ..... stakes in Abbott Laboratories, Stryker , and Nike. We cut Abbott on inflated

    9. Smith & Nephew's Solid Second Quarter Keeps the Firm on the Radar as an Acquisition Target

      Commentary

      Fri, 1 Aug 2014

      standing midtier orthopedic companies, Smith & Nephew presents an attractive target to both Stryker and Johnson & Johnson, from our perspective. Though Stryker was forced to declare it would not pursue Smith & Nephew for six months, we would not

    10. Zimmer Sees Anemic Domestic Demand Offset by Stronger International Markets in 2Q

      Commentary

      Thu, 24 Jul 2014

      growth of 1% in constant currency, Zimmer trailed rivals Stryker and Johnson & Johnson's DePuy business. In recent quarters ..... Zimmer's geographical contributions were a mirror image of Stryker 's—with much stronger international growth compensating

    « Prev12345Next »
    Content Partners